Correlation Between In8bio and Aileron Therapeutics
Can any of the company-specific risk be diversified away by investing in both In8bio and Aileron Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining In8bio and Aileron Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between In8bio Inc and Aileron Therapeutics, you can compare the effects of market volatilities on In8bio and Aileron Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in In8bio with a short position of Aileron Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of In8bio and Aileron Therapeutics.
Diversification Opportunities for In8bio and Aileron Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between In8bio and Aileron is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding In8bio Inc and Aileron Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aileron Therapeutics and In8bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on In8bio Inc are associated (or correlated) with Aileron Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aileron Therapeutics has no effect on the direction of In8bio i.e., In8bio and Aileron Therapeutics go up and down completely randomly.
Pair Corralation between In8bio and Aileron Therapeutics
Given the investment horizon of 90 days In8bio is expected to generate 3.7 times less return on investment than Aileron Therapeutics. In addition to that, In8bio is 1.41 times more volatile than Aileron Therapeutics. It trades about 0.01 of its total potential returns per unit of risk. Aileron Therapeutics is currently generating about 0.04 per unit of volatility. If you would invest 255.00 in Aileron Therapeutics on September 3, 2024 and sell it today you would earn a total of 31.00 from holding Aileron Therapeutics or generate 12.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
In8bio Inc vs. Aileron Therapeutics
Performance |
| Timeline |
| In8bio Inc |
| Aileron Therapeutics |
In8bio and Aileron Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with In8bio and Aileron Therapeutics
The main advantage of trading using opposite In8bio and Aileron Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if In8bio position performs unexpectedly, Aileron Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will offset losses from the drop in Aileron Therapeutics' long position.| In8bio vs. Reviva Pharmaceuticals Holdings | In8bio vs. Cue Biopharma | In8bio vs. Lantern Pharma | In8bio vs. Anixa Biosciences |
| Aileron Therapeutics vs. Bio Path Holdings | Aileron Therapeutics vs. Benitec Biopharma Ltd | Aileron Therapeutics vs. Artelo Biosciences | Aileron Therapeutics vs. Histogen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |